Transforming Lives
Innovation, fueled by science and a passion for patients
PTC is an established global biopharmaceutical company that delivers transformative therapies for people living with rare diseases. For 25 years, we have been harnessing our scientific platforms to create new therapies that address the underlying cause of the disease and deliver on our promise to create more moments for those who count on us.
Pioneers in Modulating Gene and Protein Expression
-
Nonsense Suppression
Bypassing translation mutations to enable protein production -
Splicing
Modulating splicing to control protein production -
Bio-e
Targeting oxidative stress and inflammation pathways to treat CNS diseases and cancer
Challenging what's possible
Harnessing groundbreaking science for patients has led to many firsts – the first approved treatment for Duchenne in the world, the first approved gene therapy directly infused into the brain, and the first approved small molecule splicing modifier. Our innovative pipeline continues to expand as we discover and develop treatments using the newest technologies available.
Clinical Trials
Click the links below to learn more about our actively enrolling trials
We love what we do
PTC employees are working to change patients’ lives every single day.
We are motivated by our patients and the drive for them to have more moments with their families, made possible in part by our research and therapies.
If you’re looking to take on rewarding work with inspiring colleagues, come grow with us.
Making headlines
-
NEWSROOM
25 Remarkable Stories: Supporting the Supporters
Inspired by the incredible impact patient advocacy groups make on the Duchenne community, PTC launched the STRIVE Awards Program in 2015. Read more about the Remarkable Story of STRIVE. -
NEWSROOM
PTC’s Top 3 Goals for the FIPFA Powerchair Football World Cup
Partnering with FIPFA for the Powerchair Football World Cup 2023 underpins PTC’s commitment to the community and provides compelling opportunities to further the progress of people with disabilities and achieve extraordinary things on-and-off the field. -
NEWSROOM
Advocacy in Action: Diagnosis & Disease Awareness
What can patients and caregivers do more specifically to advocate on behalf of a rare disease diagnosis? Check out this Q&A to learn more with Anne Bruns, Senior Director, Clinical Patient Engagement, Global.
PTC works closely with healthcare providers to support their needs
Support for the PTC patient, family, and caregiver community
Explore our investor relations section and sign up for alerts on important PTC developments